SimoTech, the largest Irish-owned automation and manufacturing IT company, serving 10 of the top 20 global pharma and biotech manufacturers, has been acquired by Project Farma. Project Farma, a GMP manufacturing services provider, now integrates specialized digital automation expertise with its compliance frameworks, according to Barchart.
Life sciences manufacturing demands rigorous GMP compliance. However, the accelerating pace of digital transformation often creates a gap in seamlessly integrating these two essential operational pillars.
Integrated digital manufacturing and GMP compliance will become a new industry standard, likely compelling competitors to develop similar end-to-end offerings to remain relevant.
SimoTech's Expertise and Market Footprint
SimoTech's established leadership in GMP IT systems and automation makes it a valuable asset. As the largest Irish-owned automation and manufacturing IT company, it serves 10 of the top 20 global pharma and biotech manufacturers, according to Barchart and Automa. SimoTech's market reach positions the combined entity to rapidly standardize integrated digital compliance solutions.
Forging an End-to-End Digital Manufacturing Solution
The acquisition creates an end-to-end service. It combines SimoTech's automation and GMP IT skills with Project Farma's existing expertise. This offering spans strategic planning through ongoing operations, according to Dealroom. SimoTech's work in automation and digital transformation directly contributes to faster, safer, and more reliable manufacturing processes, Simotechnology reports. The merger addresses the critical industry need for both advanced digital transformation and stringent GMP compliance.
